Two giants of commercial gene research, Celera Genomics of Rockville,
Maryland, and Geron of Menlo Park, California, signed a deal this week to work
towards growing brand new organs from a patient’s own cells. Geron has a unique
supply of human stem cells, which can theoretically grow into particular sorts
of tissue, while sequencing heavyweight Celera will identify genes which control
tissue formation in embryos. “Our work under this alliance will bring us one
step closer to realising the therapeutic potential of human stem cells,” says
Thomas Okarma, Geron’s president.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Advertorial
The defence sector can’t adopt a ‘one-size-fits-all’ approach to AI
Advertising
Advertorial
Why the future of defence is drone tech and distributed edge computing
Advertising
Advertorial
The future of defence lies in transatlantic industrial partnerships
Advertising
Advertorial
The biggest defence risk is a lack of integration, not technology
Advertising
Popular articles
Trending Â鶹´«Ã½ articles
1
A quantum state that lasts forever may finally be within our grasp
2
We've found a mysterious substance on Titan and Pluto
3
Autism may have two distinct subtypes that vary by brain activity
4
We may have finally solved cosmology's chicken-or-the-egg problem
5
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
6
Â鶹´«Ã½ recommends an excellent look at the future of work
7
The relationship recession is even bigger for Gen Z than we thought
8
Fully autonomous drones have killed human soldiers for the first time
9
Most portable air conditioners suck – but there's an easy fix
10
Faecal transplant makes the brains of old mice act young again
